The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk.
paper
Cited
Public
Unavailable
- Authors
- Zhang, H; Kranzler, H R; Yang, B-Z; Luo, X; Gelernter, J
- Year
- 2008
- Journal
- Molecular psychiatry
- PMID
- 17622222
- DOI
- 10.1038/sj.mp.4002035
- PMCID
- PMC3163084
Eleven single-nucleotide polymorphisms (SNPs) spanning OPRD1 were examined in 1063 European Americans (EAs) (620 cases with substance dependence (SD), including 557 with alcohol dependence (AD), 225 with cocaine dependence (CD) and 111 with opioid dependence (OD), and 443 controls). Nominally significant associations (P<0.05) of five SNPs with SD were observed; only the association of the non-synonymous variant G80T with OD remained significant after correction for multiple testing using SNPSpD. Haplotype analyses with six tag SNPs indicated that a specific haplotype GCAACT, which harbors G80T G-allele and C921T C-allele, was significantly associated with AD (chi(2)=14.82, degrees of freedom (d.f.)=1, P<0.001), CD (chi(2)=9.19, d.f.=1, P=0.002) and OD (chi(2)=20.68, d.f.=1, P<0.001). Logistic regression analyses, with sex and age being considered, demonstrated that this haplotype had a risk effect on AD (P=0.03, beta=1.86, odds ratio (OR)=6.43) and especially on OD (P<0.001, beta=3.92, OR=50.57). Moreover, seven SNPs covering OPRK1 were examined in the majority of the above subjects (390 cases, including 327 AD, 177 CD and 97 OD subjects, and 358 controls). Although no significant differences in allele, genotype or haplotype frequency distributions were seen between cases and controls, a specific OPRK1 haplotype, GGCTTCT, was significantly associated with AD (chi(2)=8.12, d.f.=1, P=0.004). Logistic regression analyses also revealed its risk effect on AD (P=0.009, beta=1.06, OR=2.90). Population stratification artifact was not observed in the sample. Taken together, our findings supported a positive association between OPRD1 variants and SD, and a positive haplotypic association between OPRK1 and AD in EAs.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2025 | β |
| Effects of PDYN 68-bpVNTR, BDNF rs6265, OPRD1 rs569356 and OPRM1 rs2075572 polymorphisms on opioid-methamphetamine co-use. | Ak M et al. | β | 2025 | β |
| Genetic and Epigenetic Approaches to Opioid Use Disorder. | Ranadeva ND et al. | β | 2025 | β |
| Nonpharmacological and pharmacological influences on opioid effects: A review of clinical research findings. | Luba R et al. | β | 2025 | β |
| Chronic intermittent ethanol exposure-induced m6A modifications around mRNA stop codons of opioid receptor genes. | Liu Y et al. | β | 2024 | β |
| Genetic factors associated with suicidal behaviors and alcohol use disorders in an American Indian population. | Peng Q et al. | β | 2024 | β |
| Synaptic Structure and Transcriptomic Profiling of Reward and Sensory Brain Areas in Male Mice of Fentanyl Addiction. | Feng J et al. | β | 2024 | β |
| Association of <i>OPRK1</i> rs963549 and rs997917 polymorphisms with opioid use disorder and related phenotypes. | Γzkan-KotiloΔlu S et al. | β | 2023 | β |
| Effect of PDYN and OPRK1 polymorphisms on the risk of alcohol use disorder and the intensity of depressive symptoms. | Γzkan-KotiloΔlu S et al. | β | 2023 | β |
| Genetic Factors Associated with Suicidal Behaviors and Alcohol Use Disorders in an American Indian Population | Peng Q et al. | β | 2023 | β |
| Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis. | Blum K et al. | β | 2023 | β |
| Predictors of treatment retention and survival among methadone-maintained patients: A possible role for a functional delta opioid receptor gene variant. | Peles E et al. | β | 2023 | β |
| CpH methylome analysis in human cortical neurons identifies novel gene pathways and drug targets for opioid use disorder. | Nagamatsu ST et al. | β | 2022 | β |
| Endogenous opioid systems alterations in pain and opioid use disorder. | Higginbotham JA et al. | β | 2022 | β |
| Novel digital approaches to the assessment of problematic opioid use. | Freda PJ et al. | β | 2022 | β |
| Pharmacogenetics of Addiction Therapy. | Graham DP et al. | β | 2022 | β |
| A review of the existing literature on buprenorphine pharmacogenomics. | Meaden CW et al. | β | 2021 | β |
| A systems omics-based approach to decode substance use disorders and neuroadaptations. | Veerappa A et al. | β | 2021 | β |
| Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study. | Al-Eitan LN et al. | β | 2021 | β |
| The OPRD1 rs678849 variant influences outcome of disulfiram treatment for cocaine dependency in methadone-maintained patients. | Thomas PS et al. | β | 2021 | β |
| The phenomics and genetics of addictive and affective comorbidity in opioid use disorder. | Freda PJ et al. | β | 2021 | β |
| A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder. | SeguΓ HA et al. | β | 2020 | β |
| Association of opioid receptor gene polymorphisms with drinking severity and impulsivity related to alcohol use disorder in a Korean population. | Park CI et al. | β | 2020 | β |
| Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence. | Fang CP et al. | β | 2020 | β |
| Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine. | Abijo T et al. | β | 2020 | β |
| Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic. | Balyan R et al. | β | 2020 | β |
| Silver nanoparticles (Ag-NPs) in the central amygdala protect the rat conditioned by morphine from withdrawal attack due to naloxone via high-level nitric oxide. | Rahimpour M et al. | β | 2020 | β |
| The Streetlight Effect: Reappraising the Study of Addiction in Light of the Findings of Genome-wide Association Studies. | Hall FS et al. | β | 2020 | β |
| Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone. | Jones JD et al. | β | 2019 | β |
| Lack of Association between Opioid-Receptor Genotypes and Smoking Cessation Outcomes in a Randomized, Controlled Naltrexone Trial. | Roche DJO et al. | β | 2019 | β |
| Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders. | Burns JA et al. | β | 2019 | β |
| Pharmacogenetics of alcohol use disorder treatments: an update. | Hartwell EE et al. | β | 2019 | β |
| Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioidΒ use disorder. | Crist RC et al. | β | 2019 | β |
| An analysis of genetic association in opioid dependence susceptibility. | Nagaya D et al. | β | 2018 | β |
| Delta Opioid Pharmacology in Relation to Alcohol Behaviors. | Alongkronrusmee D et al. | β | 2018 | β |
| Fine-Tuning Limited Proteolysis: A Major Role for Regulated Site-Specific O-Glycosylation. | Goth CK et al. | β | 2018 | β |
| Genetic association analyses and meta-analysis of Dynorphin-Kappa Opioid system potential functional variants with heroin dependence. | Yuanyuan J et al. | β | 2018 | β |
| Opioid Receptors Gene Polymorphism and Heroin Dependence in Iran. | Soleimani Asl S et al. | β | 2018 | β |
| OPRD1 Genetic Variation and Human Disease. | Crist RC et al. | β | 2018 | β |
| Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human Ξ΄-opioid receptor turnover at the plasma membrane. | Lackman JJ et al. | β | 2018 | β |
| Association of OPRD1 Gene Variants with Opioid Dependence in Addicted Male Individuals Undergoing Methadone Treatment in the North of Iran. | Sharafshah A et al. | β | 2017 | β |
| Association of OPRK1 gene polymorphisms with opioid dependence in addicted men undergoing methadone treatment in an Iranian population. | Albonaim A et al. | β | 2017 | β |
| Biochemical Diagnosis in Substance and Non-substance Addiction. | Shen W et al. | β | 2017 | β |
| Effects of selection for ethanol preference on gene expression in the nucleus accumbens of HS-CC mice. | Colville AM et al. | β | 2017 | β |
| Impact of SNP-SNP interaction among ABCB1, ARRB2, DRD1 and OPRD1 on methadone dosage requirement in Han Chinese patients. | Luo R et al. | β | 2017 | β |
| Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol. | Anderson RI et al. | β | 2017 | β |
| A delta-opioid receptor genetic variant is associated with abstinence prior to and during cocaine dependence treatment. | Crist RC et al. | β | 2016 | β |
| Cerebellum Transcriptome of Mice Bred for High Voluntary Activity Offers Insights into Locomotor Control and Reward-Dependent Behaviors. | Caetano-AnollΓ©s K et al. | β | 2016 | β |
| Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability. | Ouzir M et al. | β | 2016 | β |
| Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms. | Jones JD et al. | β | 2016 | β |
| Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence. | Randesi M et al. | β | 2016 | β |
| A review of pharmacogenetic studies of substance-related disorders. | Jones JD et al. | β | 2015 | β |
| Clinically relevant genetic biomarkers from the brain in alcoholism with representation on high resolution chromosome ideograms. | Manzardo AM et al. | β | 2015 | β |
| CREB-BDNF pathway influences alcohol cue-elicited activation in drinkers. | Chen J et al. | β | 2015 | β |
| Testosterone suppression in opioid users: a systematic review and meta-analysis. | Bawor M et al. | β | 2015 | β |
| The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. | Bauer IE et al. | β | 2015 | β |
| Variations in opioid receptor genes in neonatal abstinence syndrome. | Wachman EM et al. | β | 2015 | β |
| A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations. | Roussotte FF et al. | β | 2014 | β |
| Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. | Nelson EC et al. | β | 2014 | β |
| Genetics and genomics of alcohol sensitivity. | Morozova TV et al. | β | 2014 | β |
| Genetics of alcoholism. | Edenberg HJ et al. | β | 2014 | β |
| Genetics of opiate addiction. | Reed B et al. | β | 2014 | β |
| Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence. | Mistry CJ et al. | β | 2014 | β |
| Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females. | Clarke TK et al. | β | 2014 | β |
| Genome at juncture of early human migration: a systematic analysis of two whole genomes and thirteen exomes from Kuwaiti population subgroup of inferred Saudi Arabian tribe ancestry. | Alsmadi O et al. | β | 2014 | β |
| Introduction to deep sequencing and its application to drug addiction research with a focus on rare variants. | Wang S et al. | β | 2014 | β |
| Molecular imaging in alcohol dependence. | Ravan S et al. | β | 2014 | β |
| Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders. | Roussotte FF et al. | β | 2014 | β |
| Pharmacogenetics of addiction therapy. | Nielsen DA et al. | β | 2014 | β |
| Analyzing Interaction of ΞΌ-, Ξ΄- and ΞΊ-opioid Receptor Gene Variants on Alcohol or Drug Dependence Using a Pattern Discovery-based Method. | Li Z et al. | β | 2013 | β |
| An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. | Crist RC et al. | β | 2013 | β |
| Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. | Beer B et al. | β | 2013 | β |
| A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk. | Xu K et al. | β | 2013 | β |
| Case-control association analysis of polymorphisms in the Ξ΄-opioid receptor, OPRD1, with cocaine and opioid addicted populations. | Crist RC et al. | β | 2013 | β |
| Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence. | Blum K et al. | β | 2013 | β |
| Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. | Jacobs MM et al. | β | 2013 | β |
| Implications of genome wide association studies for addiction: are our a priori assumptions all wrong? | Hall FS et al. | β | 2013 | β |
| Molecular and genetic determinants of alcohol dependence. | Awofala AA | β | 2013 | β |
| NCK2 is significantly associated with opiates addiction in African-origin men. | Liu Z et al. | β | 2013 | β |
| Opioid system genes in alcoholism: a case-control study in Croatian population. | Cupic B et al. | β | 2013 | β |
| Polymorphisms of the kappa opioid receptor and prodynorphin genes: HIV risk and HIV natural history. | Proudnikov D et al. | β | 2013 | β |
| RGS17: an emerging therapeutic target for lung and prostate cancers. | Bodle CR et al. | β | 2013 | β |
| The ΞΊ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial. | Nielsen DA et al. | β | 2013 | β |
| Alcohol Dependence and Genes Encoding Ξ±2 and Ξ³1 GABAA Receptor Subunits: Insights from Humans and Mice. | Borghese CM et al. | β | 2012 | β |
| Common and specific liability to addiction: approaches to association studies of opioid addiction. | Nielsen DA et al. | β | 2012 | β |
| Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. | Ashenhurst JR et al. | β | 2012 | β |
| Dynamic risk factors in the misuse of opioid analgesics. | Pergolizzi JV et al. | β | 2012 | β |
| Genome-wide association study of alcohol dependence implicates KIAA0040 on chromosome 1q. | Zuo L et al. | β | 2012 | β |
| Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence. | Zuo L et al. | β | 2012 | β |
| Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems. | Bell RL et al. | β | 2012 | β |
| Large scale association analysis for drug addiction: results from SNP to gene. | Guo X et al. | β | 2012 | β |
| The dynorphin/ΞΊ-opioid receptor system and its role in psychiatric disorders. | Tejeda HA et al. | β | 2012 | β |
| The genetics of addiction-a translational perspective. | Agrawal A et al. | β | 2012 | β |
| The genetics of the opioid system and specific drug addictions. | Levran O et al. | β | 2012 | β |
| Variation in regulator of G-protein signaling 17 gene (RGS17) is associated with multiple substance dependence diagnoses. | Zhang H et al. | β | 2012 | β |
| Zebrafish: a model for the study of addiction genetics. | Klee EW et al. | β | 2012 | β |
| ΞΊ-opioid receptor/dynorphin system: genetic and pharmacotherapeutic implications for addiction. | Butelman ER et al. | β | 2012 | β |
| A polymorphism of the CREB binding protein (CREBBP) gene is a risk factor for addiction. | Kumar D et al. | β | 2011 | β |
| Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking. | SarajΓ€rvi T et al. | β | 2011 | β |
| Fine mapping quantitative trait loci that influence alcohol preference behavior in the High and Low Alcohol Preferring (HAP and LAP) mice. | Bice PJ et al. | β | 2011 | β |
| Genetics of alcohol dependence. | Kimura M et al. | β | 2011 | β |
| Molecular mechanisms of opioid receptor-dependent signaling and behavior. | Al-Hasani R et al. | β | 2011 | β |
| Pharmacogenetics of new analgesics. | LΓΆtsch J et al. | β | 2011 | β |
| ADH1A variation predisposes to personality traits and substance dependence. | Zuo L et al. | β | 2010 | β |
| Functional impact of a single-nucleotide polymorphism in the OPRD1 promoter region. | Zhang H et al. | β | 2010 | β |
| Genetics of drug dependence. | Gelernter J et al. | β | 2010 | β |
| Pharmacogenetics of alcohol and alcohol dependence treatment. | Kranzler HR et al. | β | 2010 | β |
| Pharmacogenetics of drug dependence: role of gene variations in susceptibility and treatment. | Khokhar JY et al. | β | 2010 | β |
| Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. | Yuferov V et al. | β | 2010 | β |
| The role of microRNAs in drug addiction: a big lesson from tiny molecules. | Pietrzykowski AZ | β | 2010 | β |
| Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes? | Hansell NK et al. | β | 2009 | β |
| Current evidence for a modulation of low back pain by human genetic variants. | Tegeder I et al. | β | 2009 | β |
| Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. | Walwyn W et al. | β | 2009 | β |
| Endogenous opiates and behavior: 2008. | Bodnar RJ | β | 2009 | β |
| Opiate and cocaine addiction: from bench to clinic and back to the bench. | Kreek MJ et al. | β | 2009 | β |
| Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor. | LeskelΓ€ TT et al. | β | 2009 | β |
| Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. | Zhang H et al. | β | 2009 | β |
| Susceptibility locus in neurokinin-1 receptor gene associated with alcohol dependence. | Seneviratne C et al. | β | 2009 | β |
| A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence. | Edenberg HJ et al. | β | 2008 | β |
| Genetic susceptibility to heroin addiction: a candidate gene association study. | Levran O et al. | β | 2008 | β |
| Multiple OPR genes influence personality traits in substance dependent and healthy subjects in two American populations. | Luo X et al. | β | 2008 | β |
| The genetics of alcohol and other drug dependence. | Dick DM et al. | β | 2008 | β |